Melinda Langdon

Director of Marketing and Communications at the @IvyBrainTumCtr

[Ivy Brain Tumor Center @IvyBrainTumCtr]

Dr. @NaderSanai at the @CNS_Update Annual Meeting reported progress in our Phase 0/1 trial of Sonodynamic Therapy, a potential new non-surgical treatment option for glioblastoma patients. 👏 #2024CNS

[Melinda Langdon @Melindawn]

@NaderSanai Forever a legend.

[Ivy Brain Tumor Center @IvyBrainTumCtr]

The first patient has been dosed in the Ivy Center's global, registrational, randomized, controlled Phase 3 clinical trial, Gliofocus. This study, supported by @GSK, will compare niraparib vs TMZ in newly diagnosed MGMT-unmethylated glioblastoma patients. https://t.co/fJ4UmUhg0l

[Ivy Brain Tumor Center @IvyBrainTumCtr]

In honor of #GBMDay, we have a special podcast episode! This month, we feature the powerful stories of three women who have all been impacted by glioblastoma. Their journeys of strength, determination, and hope are inspiring.💙

Listen now 👉 https://t.co/NkCOQMwABS

[Melinda Langdon @Melindawn]

Thank you for your support of brain tumor research, @SenMarkKelly! @IvyBrainTumCtr is progressing towards a cure. #GBMDay

[Senator Mark Kelly @SenMarkKelly]

On #GlioblastomaAwarenessDay, we honor those lost to this aggressive brain cancer, including the late Senator John McCain. As doctors and researchers work toward treatments and a cure — including here in Arizona at the @IvyBrainTumCtr — I’m hopeful we can beat this disease.

[Ivy Brain Tumor Center @IvyBrainTumCtr]

To conclude #BTAM, @12News highlighted the journey of Ivy Center patient Marie Donahue. Following a brain tumor diagnosis, she embraced adventure and gained a new outlook on life. Discover how Marie transformed hardship into an inspiring opportunity.
📺: https://t.co/CSXezliuri

[Ivy Brain Tumor Center @IvyBrainTumCtr]

At the Ivy Center, every clinical trial brings us one step closer to finding a cure for brain cancer. Every challenge is an opportunity; every small win is a victory.
Watch our latest video to see how we're turning Trials into Triumph. Share to help us spread hope and drive awareness of the importance of clinical trials.
🎬: https://t.co/uO5ofZZZ9K

[Ivy Brain Tumor Center @IvyBrainTumCtr]

The Ivy Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival for newly diagnosed glioblastoma patients. Supported by @GSK, we are initiating a global, Phase 3 trial of niraparib. #ASCO24
📰: https://t.co/oFSecl7ppe

[Nader Sanai @NaderSanai]

Monday at #ASCO2024: Niraparib + XRT Phase 0/2 in Newly Diagnosed, MGMT-Unmethylated GBM

OS= 20.3 months

#Gliofocus Study coming in June: a global, label-enabling, @IvyBrainTumCtr-sponsored, head-to-head Phase 3 trial in partnership with @GSK

[Ivy Brain Tumor Center @IvyBrainTumCtr]

Today, we recognize #WorldCancerDay at the Ivy Brain Tumor Center, where our focus is on the power of research in transforming brain cancer treatments. Our clinical trials offer new hope to patients seeking other options. 💙🌍

[Ivy Brain Tumor Center @IvyBrainTumCtr]

Our January newsletter is out now! 📰 Check out our most recent updates. In case you missed it, catch up here - https://t.co/XQ1bCLh5Rw

[Ivy Brain Tumor Center @IvyBrainTumCtr]

The 28th Annual SNO (@NeuroOnc) meeting was a fantastic experience! The Ivy Center enjoyed valuable networking, insightful sessions and engaging speakers. We're looking forward to seeing everyone next year in Houston! #SNO2023

[Maciej M Mrugala, MD, PhD, MPH, FAAN @MrugalaMaciej]

Sonodynamic therapy - a new hope in neuro-oncology? Interesting symposium at #SNO2023 - great presentations by @NaderSanai @IvyBrainTumCtr and @TerryBurnsLab @MayoClinic

[Ivy Brain Tumor Center @IvyBrainTumCtr]

Insightful presentation by Dr. @charutafurey!👏 She discusses the Ivy Center’s first reported experience of serial CSF liquid biopsy to monitor DNA- and RNA-based tumor evolution in the context of an experimental therapy.

[Shwetal Mehta, Ph.D. (she/her) @smehtalab]

As always, amazing presentation @NeuroOnc by @IvyBrainTumCtr ‘s rising star @charutafurey on early results from our longitudinal CSF liquid biopsy project on samples collected from our Niraparib phase 0/2 trial in collaboration with @roelverhaak @SBAmin @Kevin_C_Johnson #SNO2023

[Ivy Brain Tumor Center @IvyBrainTumCtr]

Dr. @NaderSanai presented encouraging findings this morning at #SNO2023 from a Phase 0/2 clinical trial of niraparib. We're excited about further exploring the potential role of this drug with @GSK for patients with MGMT-unmethylated #glioblastoma.
📰: https://t.co/f1fkJ3z6Yy

[Melinda Langdon @Melindawn]

@IvyBrainTumCtr Soooo good!! 😋

[Shwetal Mehta, Ph.D. (she/her) @smehtalab]

Fantastic talk by @Kevin_C_Johnson on our collaborative project with @roelverhaak lab focusing on snRNAseq analysis of phase 0 samples from Ribociclib+Everolimus trial @IvyBrainTumCtr and impact of CDK4/6i on cell state change in recurrent high grade gliomas @NeuroOnc #SNO2023

[Shwetal Mehta, Ph.D. (she/her) @smehtalab]

.@NaderSanai on a roll with third talk of the day on results from @IvyBrainTumCtr Phase 0/1b trial of AZD1390 in recurrent #GBM @NeuroOnc #SNO2023

[Melinda Langdon @Melindawn]

@IvyBrainTumCtr @YoshieUmemura 👏🏻👏🏻👏🏻